Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.54 |
| ▸ | HTR2C | P28335 | 5/20 | 0.54 |
| ▸ | HTR2B | P41595 | 4/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | HTR1A | P08908 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28211962 | 0.94 | HTR2A (0.50) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL481617 | 0.90 | HTR2A (0.47) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL481354 | 0.87 | CYP3A4 (0.48) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL7139169 | 0.87 | HTR2A (0.46) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL27560259 | 0.87 | MAPT (0.50) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL5531158 | 0.87 | HTR2A (0.46) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL16024606 | 0.85 | PDE4A (0.44) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL13805536 | 0.84 | POLB (0.58) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL22342696 | 0.84 | HTR2A (0.44) | HTR2AHTR2CHTR2BCYP3A4HTR1A | |
| SCHEMBL22595830 | 0.84 | HTR2A (0.44) | HTR2AHTR2CHTR2BCYP3A4HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116375682-B | Electrochromic material based on bithiophene, preparation method thereof and electrochromic film | 平湖市浙江工业大学新材料研究院 | 2025-03-04 | — | — | CN | claimed |
| CN-116375682-A | Electrochromic material based on bithiophene, preparation method thereof and electrochromic film | 平湖市浙江工业大学新材料研究院 | 2023-07-04 | — | — | CN | claimed |
| CN-102660001-A | Synthesis method of conjugated polymer gelling agent polyphenylene ethynylene and preparation method of gel of the conjugated polymer gelata polyphenylene ethynylene | UNIV NANJING POSTS & TELECOMM | 2012-09-12 | — | — | CN | claimed |
| CN-101831054-B | Method for distinguishing fungi and bacteria | CHINESE ACAD INST CHEMISTRY | 2011-11-16 | — | — | CN | claimed |
| CN-101831054-A | Method for distinguishing fungi and bacteria | CHINESE ACAD INST CHEMISTRY | 2010-09-15 | — | — | CN | claimed |
| US-12378274-B2 | Solid solution approach for redox active metal organic frameworks with tunable redox conductivity | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| CN-115088892-B | Cationic conjugated microporous polymer modified antibacterial and antiviral mask | 陕西师范大学 | 2025-04-15 | — | — | CN | disclosed |
| CN-116375682-B | Electrochromic material based on bithiophene, preparation method thereof and electrochromic film | 平湖市浙江工业大学新材料研究院 | 2025-03-04 | — | — | CN | disclosed |
| US-20240287115-A1 | SOLID SOLUTION APPROACH FOR REDOX ACTIVE METAL ORGANIC FRAMEWORKS WITH TUNABLE REDOX CONDUCTIVITY | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | 2024-08-29 | — | — | US | disclosed |
| US-11964992-B2 | Solid solution approach for redox active metal organic frameworks with tunable redox conductivity | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| CN-117747913-A | Lithium ion battery | 珠海冠宇电池股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-113912636-B | Silicon-containing heterocyclic compound and organic electroluminescent element containing the same | 上海八亿时空先进材料有限公司 | 2023-10-27 | — | — | CN | disclosed |
| EP-1837324-A1 | PROCESS FOR PRODUCING AROMATIC IODINE COMPOUND | Nippoh Chemicals Co., Ltd (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-20070049758-A1 | Urogenital disorders; incotinence; analgesics; respiratory system disorders; gastrointestinal disorders; premenstrual tension | ROCHE PALO ALTO LLC | 2007-03-01 | — | — | US | disclosed |
| US-20070049758-A1 | Urogenital disorders; incotinence; analgesics; respiratory system disorders; gastrointestinal disorders; premenstrual tension | ROCHE PALO ALTO LLC | 2007-03-01 | — | — | US | disclosed |
| US-20070049758-A1 | Urogenital disorders; incotinence; analgesics; respiratory system disorders; gastrointestinal disorders; premenstrual tension | ROCHE PALO ALTO LLC | 2007-03-01 | — | — | US | disclosed |
| US-20070049609-A1 | Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases | ROCHE PALO ALTO LLC | 2007-03-01 | — | — | US | disclosed |
| US-20070049609-A1 | Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases | ROCHE PALO ALTO LLC | 2007-03-01 | — | — | US | disclosed |
| US-5243060-A | Polymerization of diethynyl silane and dihaloarylene in the presence of a catalyst | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1993-09-07 | — | — | US | disclosed |
| US-4647446-A | Rapid brain scanning radiopharmaceutical | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1987-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378274-B2 | Solid solution approach for redox active metal organic frameworks with tunable redox conductivity | GPX4, FTO, GPX1 | HTR2A 4062/4885HTR2C 4256/4885HTR2B 4841/4885 |
| US-20070049758-A1 | Urogenital disorders; incotinence; analgesics; respiratory system disorders; gastrointestinal disorders; premenstrual tension | P2RX3, P2RX1, P2RX2 | HTR2A 315/4885HTR2C 206/4885HTR2B 112/4885 |
| US-20240287115-A1 | SOLID SOLUTION APPROACH FOR REDOX ACTIVE METAL ORGANIC FRAMEWORKS WITH TUNABLE REDOX CONDUCTIVITY | GPX4, FTO, GPX1 | HTR2A 4062/4885HTR2C 4256/4885HTR2B 4841/4885 |
| US-20070049609-A1 | Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases | P2RX3, P2RX2, P2RX1 | HTR2A 730/4885HTR2C 719/4885HTR2B 378/4885 |
| US-11964992-B2 | Solid solution approach for redox active metal organic frameworks with tunable redox conductivity | GPX4, FTO, GPX1 | HTR2A 4062/4885HTR2C 4256/4885HTR2B 4841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.